Building Operational Visibility in Clinical Trials: Q&A with Deepak Prakash

Key Takeaways

• RFID/Bluetooth tags provide continuous location and condition data for trial assets.
• Real-time tracking cuts manual reconciliation, lowering operational costs and errors.
• Item‑level monitoring reduces cold‑chain waste, addressing $35 billion loss.
• Digital labeling enhances patient usability, improving adherence in decentralized trials.
• Integrated visibility aligns supply with demand, streamlining trial logistics.

Pulse Analysis

The rapid expansion of clinical trials across multiple continents and decentralized sites has outpaced legacy data‑capture systems, creating blind spots that jeopardize timelines and data fidelity. RFID and Bluetooth technologies embed sensors directly onto drug shipments, sample containers, and trial devices, transmitting location, temperature, and handling status to cloud platforms in real time. This shift from point‑in‑time checkpoints to continuous streams enables sponsors to detect deviations instantly, reducing manual reconciliation and freeing resources for higher‑value analysis.

Supply‑chain disruptions have long plagued the pharmaceutical industry, with the IQVIA Institute estimating $35 billion in annual losses from temperature‑controlled logistics failures. Item‑level monitoring transforms the cold chain by providing granular, per‑unit condition data, allowing logistics teams to intervene before spoilage occurs. The result is a measurable reduction in waste, tighter alignment of inventory with patient demand, and lower overall trial costs—benefits that resonate across manufacturers, CROs, and logistics providers alike.

Beyond logistics, digital labeling and smart packaging are redefining patient interaction in decentralized trials. Interactive labels can deliver multilingual audio instructions, capture dosing events, and relay environmental metrics back to study coordinators, thereby improving adherence and data reliability. As trials increasingly rely on remote participants, these technologies bridge the gap between clinical sites and home environments, ensuring consistent data capture and enhancing overall trial integrity. The convergence of real‑time tracking and digital packaging positions the industry to conduct more complex, patient‑centric studies at scale while maintaining rigorous quality standards.